International safety notice
Corrective action for the product LIAISON® Biotrin Parvovirus B19 IgM, DiaSorin S.p.A.
Germany / BfArM · DEU · Nov 4, 2014
Key facts
| Title | Corrective action for the product LIAISON® Biotrin Parvovirus B19 IgM, DiaSorin S.p.A. |
|---|---|
| Regulator | Germany / BfArM |
| Country | DEU |
| Brand | the product LIAISON® Biotrin Parvovirus B19 IgM, DiaSorin S.p.A. |
| Manufacturer | Corrective action for the product LIAISON® Biotrin Parvovirus B19 IgM, DiaSorin S.p.A. |
| Models | 317010, 129022X, 13040, 2014FOR, 39.0161.487.849, V6191M |
| Date | Nov 4, 2014 |
| Regulator page | bfarm.de |
At a glance
- No Recall
- No Field safety notice
- 1–9 Matching device models in FDA data
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About International device safety notices
Field safety notices, recalls and safety alerts published by about 30 national medical device regulators outside the United States, matched by Orca1 to FDA device data.
Source: National medical device regulators (as listed), compiled by Orca1